Submission of Matters to a Vote of Security Holders - Form 8-K

Item 5.07

Submission of Matters to a Vote of Security Holders.

On May 14, 2024, Harvard Bioscience, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders, at which the Company's stockholders voted on three proposals that are described in detail in the Company's Definitive Proxy Statement filed with the Securities and Exchange Commission on April 3, 2024.

The voting results for each of the proposals are reported below.

Proposal 1 - Election of Director

The Company's stockholders elected one Class III Director for a three-year term, such term to continue until the annual meeting of stockholders in 2027 and until such director's successor is duly elected and qualified or until his earlier resignation or removal.

Name

Votes For

Votes Withheld

Broker Non-Votes

Alan Edrick

19,722,574

10,861,497

4,292,458

Proposal 2 -Ratification of the Appointment of Grant Thornton LLP

The Company's stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. There were no broker non-votes on this proposal.

Votes For		Votes Against		Votes Abstained
	34,794,995				73,003				8,531

Proposal 3 -Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers

The Company's stockholders approved the compensation of the Company's named executive officers, by a non-binding advisory vote:

Votes For		Votes Against		Votes Abstained		Broker Non-Votes
	27,472,149				903,608				2,208,314				4,292,458

Public link

Please use the above public link if you want to share this noodl on another website.